Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
人 TLR8 诱导 SLE 小鼠模型妊娠失败的机制
基本信息
- 批准号:10434117
- 负责人:
- 金额:$ 25.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-18 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmino AcidsAntibodiesAntigen-Antibody ComplexAntiphospholipid AntibodiesAttenuatedAutoantibodiesAutoimmune DiseasesAutoimmunityB-Lymphocyte SubsetsB-LymphocytesBacterial Artificial ChromosomesBindingBinding SitesBlood VesselsCell LineCell LineageCellsCharacteristicsDevelopmentDoseExposure toFemaleFetal DeathFetal ResorptionGene ExpressionGenetic PolymorphismGenetic studyGoalsHumanIL8 geneImmuneImmunologic ReceptorsIn VitroInflammationInflammatoryInjuryInnate Immune SystemInterferon Type ILeadLigand BindingLigandsLupusLymphocyteMediatingMemory B-LymphocyteMessenger RNAMicroRNAsModelingMorphologyMusMyelogenousMyeloid CellsNucleic AcidsPathogenicityPathway interactionsPatientsPatternPhenotypePhospholipidsPhysiologicalPlacentaPlasma CellsPregnancyPregnancy OutcomePregnancy lossProductionPurinesQuality of lifeRNARNA BindingRibonucleasesRoleSLEB1 geneSusceptibility GeneSyndromeSystemic Lupus ErythematosusTLR7 geneTLR8 geneTestingTissuesToll-like receptorsTransgenesTransgenic MiceUridineWomanantagonistcell injurycytokineeffective therapyexperimental studyexposed human populationfetalfetal lossfetus cellimproved outcomein vivoinflammatory milieulupus prone micemacrophagemonocytemortalitymouse modelneutrophilnovelnovel strategiespathogenic autoantibodiesplacental morphologypreventpromoterreceptorrecruitresponsesensortherapeutic targettransgene expressiontrophoblast
项目摘要
Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disease that causes
a significant decrease in quality of life and early mortality. Genetic studies have identified
activation of the innate immune system, with excess production of Type I interferons as a major
causative pathway. RNA-sensing Toll-like receptors are crucial protective receptors of the innate
immune system but are also implicated in autoimmunity because they can recognize nucleic acids
released from damaged cells and within nucleic acid containing immune complexes. Functional
polymorphisms of the endosomal RNA-recognizing innate receptors TLR7 and TLR8 predispose
to SLE and excess mouse TLR7 and human TLR8 accelerate lupus in mouse models. Human
TLR8 differs in its function from TLR7 because it recognizes different ligands and is expressed
on different immune cell subsets.
TLR8 is not an RNA sensor in mice because of a 5 amino acid deletion that attenuates its
RNA-binding site. We therefore bred a human TLR8 BAC transgene (huTLR8) into mice in which
a mild lupus phenotype is conferred by the susceptibility locus Sle1. Expression of the transgene
is physiologically regulated such that huTLR8 is expressed at high levels in myeloid DCs and
monocytes but at 50-100-fold lower levels in lymphocytes. We found that huTLR8 induces an anti-
phospholipid like syndrome in Sle1 mice that leads to spontaneous placental inflammation, fetal
resorptions and late-term pregnancy loss in up to 60% of female dams. In this proposal we will
test the mechanism for huTLR8 mediated pregnancy loss by addressing the role of huTLR8 as a
sensor of RNA in placental trophoblasts and immune cells.
In Aim 1 we will examine the role of autoantibodies in placental injury in mice with or
without huTLR8 expression and determine whether huTLR8 expression in B cells results in the
production of autoantibodies with enhanced pathogenicity. In Aim 2 we will determine the timing
and characteristics of placental injury, the contribution of huTLR8 in maternal vs. fetal cells to
injury and whether placental trophoblasts activated by anti-phospholipid antibodies release
huTLR8 ligands that enhance local inflammation. In Aim 3 we will determine whether myeloid
cells from huTLR8tg mice are intrinsically more pro-inflammatory than those of their wild-type
counterparts and therefore amplify the effector response to antibody mediated placental injury.
These experiments should allow us to distinguish the role of huTLR8 in maternal cells,
trophoblasts and immune cell subsets in the induction of placental damage that leads to
pregnancy loss. Our studies will inform us whether specific huTLR8 antagonists or antagonists of
huTLR8 ligands should be tested for their ability to prevent or treat placental injury.
系统性红斑狼疮 (SLE) 是一种多系统自身免疫性疾病,可导致
生活质量和早期死亡率显着下降。遗传学研究已确定
激活先天免疫系统,其中 I 型干扰素的过量产生是主要因素
因果途径。 RNA 感应 Toll 样受体是先天性的重要保护性受体
免疫系统,但也与自身免疫有关,因为它们可以识别核酸
从受损细胞和含有免疫复合物的核酸中释放。功能性
内体 RNA 识别先天受体 TLR7 和 TLR8 的多态性易感
在小鼠模型中,SLE 和过量的小鼠 TLR7 和人 TLR8 会加速狼疮的发生。人类
TLR8 的功能与 TLR7 不同,因为它识别不同的配体并表达
针对不同的免疫细胞亚群。
TLR8 不是小鼠体内的 RNA 传感器,因为 5 个氨基酸的缺失削弱了其作用
RNA 结合位点。因此,我们将人类 TLR8 BAC 转基因 (huTLR8) 培育到小鼠体内,其中
轻度狼疮表型由易感基因座 Sle1 赋予。转基因的表达
受到生理调节,使得 huTLR8 在骨髓 DC 中高水平表达,并且
单核细胞中的水平低 50-100 倍,淋巴细胞中的水平低 50-100 倍。我们发现 huTLR8 诱导抗
Sle1 小鼠的磷脂样综合征导致自发性胎盘炎症、胎儿
高达 60% 的雌性母猪出现吸收和晚期妊娠流产。在本提案中,我们将
通过解决 huTLR8 作为
胎盘滋养层和免疫细胞中的 RNA 传感器。
在目标 1 中,我们将检查自身抗体在患有以下疾病的小鼠胎盘损伤中的作用:
没有 huTLR8 表达,并确定 B 细胞中 huTLR8 表达是否会导致
产生具有增强致病性的自身抗体。在目标 2 中,我们将确定时间
胎盘损伤的特征、母体细胞和胎儿细胞中 huTLR8 对胎盘损伤的贡献
损伤以及抗磷脂抗体激活的胎盘滋养层细胞是否释放
huTLR8 配体增强局部炎症。在目标 3 中,我们将确定是否有骨髓细胞
huTLR8tg 小鼠的细胞本质上比野生型小鼠的细胞更具促炎性
对应物,因此放大了对抗体介导的胎盘损伤的效应反应。
这些实验应该使我们能够区分 huTLR8 在母体细胞中的作用,
滋养层和免疫细胞亚群在诱导胎盘损伤中的作用,从而导致
妊娠损失。我们的研究将告诉我们是否有特定的 huTLR8 拮抗剂或 huTLR8 拮抗剂
应测试 huTLR8 配体预防或治疗胎盘损伤的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Davidson其他文献
Anne Davidson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne Davidson', 18)}}的其他基金
Dissecting the heterogeneity and function of myeloid cells in lupus nephritis
剖析狼疮性肾炎骨髓细胞的异质性和功能
- 批准号:
10588862 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10470893 - 财政年份:2021
- 资助金额:
$ 25.44万 - 项目类别:
Mechanisms for Human TLR8 induced pregnancy loss in a mouse model of SLE
人 TLR8 诱导 SLE 小鼠模型妊娠失败的机制
- 批准号:
10301657 - 财政年份:2021
- 资助金额:
$ 25.44万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10653079 - 财政年份:2021
- 资助金额:
$ 25.44万 - 项目类别:
Induction of lupus-related autoantibodies by TNF inhibitors
TNF 抑制剂诱导狼疮相关自身抗体
- 批准号:
10405223 - 财政年份:2021
- 资助金额:
$ 25.44万 - 项目类别:
T32 Training Grant in Translational Immunology
T32 转化免疫学培训补助金
- 批准号:
10269999 - 财政年份:2021
- 资助金额:
$ 25.44万 - 项目类别:
Heterogeneous pathways to autoantibody production: implications for prognosis and therapeutic targeting
自身抗体产生的异质途径:对预后和治疗靶向的影响
- 批准号:
10159859 - 财政年份:2019
- 资助金额:
$ 25.44万 - 项目类别:
相似国自然基金
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
- 批准号:22105008
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
- 批准号:91953103
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:重大研究计划
基于非天然氨基酸的蛋白质定点修饰方法研究及其在抗体药物研发中的应用
- 批准号:21602235
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
- 批准号:
10658665 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Scalable platforms for understudied histone modifications and modifiers
用于未充分研究的组蛋白修饰和修饰剂的可扩展平台
- 批准号:
10567849 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别: